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SarcomaA 53-year-old Caucasian male was evaluated for cough and
exertional dyspnea. His past medical history was signiﬁcant
for heavy cigarette smoking and recurrent pneumonias.
CT scan of the chest performed in January 2007 revealed
multiple, sub-centimeter, calciﬁed and non-calciﬁed pul-
monary nodules those were stable when compared to a scan
done in May of 2005. However, a new 6mm non-calciﬁed
nodule was noted in the right lower lobe (Figure 1(A)). In
June 2007, a repeat CT scan of the chest demonstrated
enlargement of the nodule to a diameter of 2.5 cm (Figure
1(B)). Three weeks later, PET-CT showed high uptake within
the mass (standardized uptake value maximum of 15.6) with
a new subjacent nodule measuring 1.2 2.0 cm and no
evidence of distal metastases (Figures 1(C) and (D)).ed by Elsevier Ltd.
988 3811;
C.A. Hage).Because of the patient’s good performance status, the size
of the tumor, and the lack of distant metastases, it was
decided to proceed with surgical resection with curative
intent.
During surgery, the mass was located in the superior
segment of the right lower lobe. Initial pathologic examina-
tion on frozen sections revealed poorly differentiated non-
small cell carcinoma. Microscopic examination of the tumor
revealed solid sheets of cells divided into irregular masses
by ﬁbrous strands and the majority of the cells were large
and pleomorphic containing conspicuous nucleoli. Complete
lymph node dissection was performed, and all but one
subcarinal lymph node were free of tumor. Examination by
electron microscopy showed multiple small foci of glycogen
joined by rare rudimentary cell junctions. A few dense-
cored (neurosecretory) granules were identiﬁed. Immuno-
histochemical staining showed the tumor expressed vimen-
tin, CD99 (HBA71), CMYC, neuroﬁlament, synaptophysin,
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Figure 1 (A) Chest CT, January 2007 showing a 6mm non-calciﬁed nodule in the right lower lobe. (B) Chest CT, June 2007
demonstrates signiﬁcant enlargement of the right lower lobe nodule, measuring 2.5 cm in diameter. (C) Chest CT six weeks later
showing further enlargement with an adjacent mass. (D) Whole body PET scan showing high metabolic activity in the right lower lung
with no evidence of distant metastasis.
S. Najm et al.162CD10, CDR45 and KI-67, but not the following surface
markers: MYF, Pancytokeratin, cytokeratin 7, cytokeratin
20, chromogranin, S-100, PSA and RCA (Figure 2). A diagnosis
of primitive neuroectodermal tumor (PNET) of the lung was
conﬁrmed.Discussion
PNETs are exceedingly rare in the adult population.1,2 In the
chest, PNET primarily involves the chest wall or the lung as a
distant metastasis of an extra-thoracic soft tissue sarcoma.
PNET rarely presents as a primary pulmonary neoplasm with
very few documented cases of primary lung PNET in the
literature.3,4
PNETs are part of a spectrum of neoplastic diseases known
as the Ewing’s sarcoma family of tumors, which also includes
atypical Ewing’s sarcoma,5,6 Askin’s tumor (malignant small-
cell tumor of the thoracopulmonary region),7 Neuroblasto-
ma and paravertebral small cell tumor.8 In this particular
case, the tumor was conﬁned to the posterior aspect of theright lower lobe with no chest wall involvement, suggesting
a primary lung tumor as opposed to the more common
sarcoma of the chest wall.
Over the last decade, diagnosis has greatly improved with
the introduction of an array immunohistochemical markers.
The majority of Ewing’s sarcomas (84%) have a stereotypical
immunophenotype with the expression of CD99 in all cases,
FLI1 in 90% of cases and no expression of cytokeratins or
desmin. In cases where morphology is inconclusive, cytoge-
netic analysis has rapidly become the standard for conﬁrm-
ing the diagnosis.9,10 Most PNETs are characterized by a
reciprocal translocation of the long arms of chromosomes 11
and 22, which creates a chimeric gene product of unknown
function.9
Because of their immunohistochemical and neurosecre-
tory phenotype, PNETs are thought to originate from the
neural crest, similar to neuroblastomas.11–13 However, PNETs
can arise in organs not directly related to the neural crest
(i.e. kidney) suggesting other histogenic possibilities.14
Mainstay of treatment for PNET is doxorubicin-based
chemotherapy. For patients with high-risk tumors (primany
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Figure 2 Primitive neuroectodermal tumor of the lung: (A) tumor cells are pleomorphic and undifferentiated (Hematoxylin and
Eosin stain magniﬁcation 20 (inset 40 )). (B) Tumor cells show immunopositivity for CD99 (magniﬁcation 40 ). (C) Tumor cells
are reactive for neuroﬁlament (magniﬁcation 40 ). (D) Electron micrograph shows undifferentiated tumor cells with rudimentary
cell junctions (magniﬁcation 1900 ).
Lung PNET 163larger than 5 cm, local recurrence or of high grade), overall
survival is improved with regimens including anthracycline
and ifosfamide with growth factor support with survival
beneﬁt noted only for extremity sarcomas.
The decision of surgical resection was based on the pre-
operative clinical and radiographic staging (I-B). Surgery
revealed a positive lymph node consequently changing the
stage to II-B. The patient was given adjuvant chemotherapy
with one cycle of cyclophosphamide, adriamycin and
vincristine followed by two cycles of ifosfamide, etoposide
and mesna. The patient is currently doing well with no
evidence of recurrence after nine months of treatment.
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